Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- R&D NEWS IN BRIEF
July 9, 2007
- MediBIC Group Announces Restructuring Plan to Focus on PGx
July 9, 2007
- NAG Increases Water Content in the Skin: Dr Tsubouchi
July 9, 2007
- Merger with MPC Approved by Tanabe's Shareholders
July 9, 2007
- SELF-MEDICATION NEWS IN BRIEF
July 9, 2007
- NEW PRODUCTS／Ajinomoto Launches Acetate-Free Carbostar Dialysate
July 9, 2007
- Roche to Initiates TOB to Acquire Ventana
July 9, 2007
- BUSINESS NEWS IN BRIEF
July 9, 2007
- MEDICAL DEVICE NEWS IN BRIEF
July 9, 2007
- TOPICS／Biopharmaceutical Plant Market Expected to Grow to \17 Bil. in 2010: Fuji Keizai
July 9, 2007
- Financial Support from Gov't, Private Sector Essential for Healthcare Clusters: Council
July 9, 2007
- List of Discussion Topics on Drug Pricing Reform Proposed
July 9, 2007
- Korosho to Expand Insurance Coverage for Living Liver Transplantation
July 9, 2007
- Increases in Premiums Proposed by DPO Chairman
July 9, 2007
- Psychoneurotic Drugs Account for 40% of Consultations on Drugs during Pregnancy
July 9, 2007
- Eli Lilly Japan Files NDA for AD/HD Drug Atomoxetine
July 9, 2007
- SURVEY／3 out of 4 Women Experience Hemorrhoids
July 9, 2007
- REGULATORY NEWS IN BRIEF
July 9, 2007
- seminar／Use of New Anticancer Agents Should Be Restricted to Specialists for Fixed Period
July 9, 2007
- JGPMA to Discuss Full Membership Affiliation with the IGPA
July 9, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…